Prof. Fabian Kiessling, RWTH Aachen, Institute of Experimental Molecular Imaging

Quantitative hybrid fluorescence and CT to assess drug biodistribution in cancer research

CT, Optical

Fabian Kiessling presents some aspects of their research on optical tomography. For a detailed biodistribution analysis, PET and SPECT are usually preferred as they are more accurate and quantitative, so the question is, can optical imaging become a complementary tool for pre-clinical biodistribution analysis?

The talk took place at the EMIM 2022.

Related webinars

In vivo molecular imaging for the preclinical development and validation of radiopharmaceuticals
In vivo molecular imaging for the preclinical development and validation of radiopharmaceuticals
Multiscale optical imaging for unraveling the in vivo fate of nanomedicine
Multiscale optical imaging for unraveling the in vivo fate of nanomedicine
No results found.
Share this webinar

Want to know what MILabs can do for you?